Related Experiment Video
Updated: Aug 10, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Advances in the pathogenesis and treatment of acute coronary syndromes
C A Thompson1, J D Danzell, H G Hanley
1Department of Internal Medicine, Louisiana State University School of Medicine, Shreveport, USA.
Insights
Acute coronary syndromes, including unstable angina and myocardial infarction, require prompt treatment. While reperfusion is key for ST elevation myocardial infarction, newer therapies like enoxaparin show promise for other acute coronary syndromes.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Unstable angina, non-Q wave myocardial infarction, and Q wave myocardial infarction are linked by shared pathogenesis under acute coronary syndromes.
- Prompt reperfusion via thrombolysis or percutaneous transluminal coronary angioplasty is established for acute ST segment elevation myocardial infarction.
Purpose of the Study:
- To review the established and emerging treatments for acute coronary syndromes.
- To highlight advances in managing unstable angina and non-Q wave myocardial infarction.
Main Methods:
- Review of current therapeutic strategies for acute coronary syndromes.
- Evaluation of the efficacy and potential harms of different treatment modalities.
Main Results:
- Thrombolysis may be disappointing or harmful in unstable angina and non-Q wave myocardial infarction.
- Traditional therapies (morphine, oxygen, nitrates, aspirin, heparin, beta blockers) are indicated for all acute coronary syndromes.
- Enoxaparin and platelet glycoprotein IIb/IIIa receptor antagonists show particular effectiveness in unstable angina/non-Q wave myocardial infarction.
Conclusions:
- Treatment strategies for acute coronary syndromes vary based on specific clinical entities.
- Enoxaparin and glycoprotein IIb/IIIa inhibitors represent significant advances for unstable angina and non-Q wave myocardial infarction management.
Abstract:
The clinical entities of unstable angina, non-Q wave myocardial infarction, and Q wave myocardial infarction share the same pathogenesis and, because of this, are linked under the heading of acute coronary syndromes. Prompt reperfusion in the early phase of acute ST segment elevation myocardial infarction, with thrombolysis or percutaneous transluminal coronary angioplasty, now has an established place in the treatment of this condition. However, thrombolysis has been disappointing and may be harmful in the treatment of unstable angina and non-Q wave myocardial infarction. While traditional therapy with morphine, oxygen, nitrates, aspirin, heparin, and beta blockers may be indicated in the treatment of all types of acute coronary syndromes, recent studies have led to advances in the treatment of unstable angina/non-Q wave myocardial infarction patients. In these patients, enoxaparin (a low molecular weight heparin) and the platelet glycoprotein IIb/IIIa receptor antagonists may be particularly effective.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

